Endeavor BioMedicines

Pushing Boundaries to Change Lives

Endeavor BioMedicines was founded in 2019, is headquartered in San Diego, United States, lists 11–50 employees, and has $295.5M in recorded funding across 3 rounds.

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$295.5M
Last Round
$132.5M Series CApr 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 7 investors for this company. The full record is or through the API.

About

Endeavor BioMedicines is a clinical-stage biotechnology company headquartered in San Diego that develops transformational medicines for patients with life-threatening and intractable diseases. Co-founded by CEO John Hood, PhD, the company's lead pipeline targets fibrotic lung disease, including Taladegib (ENV-101), which aims to reverse rather than merely slow disease progression and has received PRIME designation from the European Medicines Agency. Endeavor has raised financing including a $132.5 million oversubscribed Series C round to advance its pipeline.

Summary

Endeavor BioMedicines is a Biotech company based in San Diego, United States, founded in 2019. It lists 11–50 employees. It has raised $295.5M in total across 3 rounds, most recently a $132.5M Series C round in Apr 2024. Investors include Matrix Capital Management, Ally Bridge Group and Fidelity Management.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CApr 2024
$132.5M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Endeavor BioMedicines on Indexed.vc
<a href="https://indexed.vc/companies/endeavor-biomedicines"><img src="https://indexed.vc/api/badge/company/endeavor-biomedicines" alt="Endeavor BioMedicines on Indexed.vc" width="260" height="76" /></a>